Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001289000 | SCV001476478 | benign | not specified | 2020-02-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002486088 | SCV002797908 | likely benign | Maturity-onset diabetes of the young type 1; Type 2 diabetes mellitus; Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young | 2021-08-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002543000 | SCV003249925 | likely benign | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV003148971 | SCV003804960 | likely benign | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Potent mutations in HNF4A are associated with poor insulin secretion in response to hyperglycemia. Associated with MODY1. Patients initially respond well to sulfonylureas but eventually become insulin dependent. However, more evidence is required to ascertain the role of this particular variant rs760811566 in MODY, yet. | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001289000 | SCV005077589 | likely benign | not specified | 2024-04-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003148971 | SCV005601294 | likely benign | Maturity onset diabetes mellitus in young | 2024-08-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |